DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/6lbxj2/global) has announced the addition of the "Global Atherosclerosis Drug Pipeline Capsule - 2012 Update" report to their offering.
“Global Atherosclerosis Drug Pipeline Capsule - 2012 Update”
Fore Pharma's latest report 'Global Atherosclerosis Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Atherosclerosis market. It covers active Atherosclerosis pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.
This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.
The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.
Topics Covered:
1. Atherosclerosis - Disease Overview
2. Atherosclerosis Pipeline Overview
3. Atherosclerosis Phase 3 Clinical Trial Pipeline Insights
4. Atherosclerosis Phase 2 Clinical Trial Pipeline Insights
5. Atherosclerosis Phase 1 Clinical Trial Pipeline Insights
6. Atherosclerosis Preclinical Research Pipeline Insights
7. Atherosclerosis Discovery Stage Pipeline Insights
8. Atherosclerosis Drug Development Activities - Geographic Landscape
8.1. Atherosclerosis R&D Activities in North America
8.2. Atherosclerosis R&D Activities in Europe
9. Atherosclerosis Pipeline - Licensing Activities
Table 1. Atherosclerosis Pipeline Molecules - Phase 3 Clinical Trial
Table 2. Atherosclerosis Pipeline Molecules - Phase 2 Clinical Trial
Table 3. Atherosclerosis Pipeline Molecules - Phase 1 Clinical Trial
Table 4. Atherosclerosis Pipeline Molecules - Preclinical Research
Table 5. Atherosclerosis Pipeline Molecules - Drug Discovery
Table 6. Atherosclerosis R&D Activities by Geography
Table 7. Atherosclerosis Pipeline Molecules - North America
Table 8. Atherosclerosis Pipeline Molecules - Europe
Table 9. Atherosclerosis Pipeline - Licensing Activities
Figure 1. Atherosclerosis Pipeline Molecules by R&D Stage
Figure 2. Atherosclerosis R&D Activities by Geography
For more information visit http://www.researchandmarkets.com/research/6lbxj2/global.





